Published in Eur J Pediatr on December 01, 1998
Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival. J Cell Physiol (2012) 0.91
Loss of Bone and Wnt10b Expression in Male Type 1 Diabetic Mice Is Blocked by the Probiotic Lactobacillus reuteri. Endocrinology (2015) 0.85
Growth of children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol (2010) 0.82
Secular trends in growth in diabetes: are we winning? Arch Dis Child (2003) 0.81
The Relationship between Metabolic Control and Growth in Children with Type I Diabetes Mellitus in Southwest of Iran. Scientifica (Cairo) (2015) 0.75
Growth status of children and adolescents with type 1 diabetes mellitus. Indian J Endocrinol Metab (2013) 0.75
Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis. Growth Horm IGF Res (2017) 0.75
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature (1995) 8.23
Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95
Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science (1995) 4.80
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord (2001) 2.94
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med (1996) 2.65
Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol (1993) 2.45
Cellular stress response and apoptosis in cancer therapy. Blood (2001) 2.32
Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res (1997) 2.32
mAb33 from transduction laboratories specifically binds human CD95-L. Cell Death Differ (2000) 1.97
Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene (2001) 1.94
Regulation of apoptosis in the immune system. Curr Opin Immunol (1994) 1.89
TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol (1998) 1.81
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res (1997) 1.76
Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediatr (1998) 1.72
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci (1999) 1.66
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy. Blood (2001) 1.51
High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood (1994) 1.50
MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene (1999) 1.46
Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood (1996) 1.46
Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem (1998) 1.41
Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation (2000) 1.36
Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med (2009) 1.34
Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes (1996) 1.33
Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol (1997) 1.33
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene (2001) 1.32
The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus. Diabetologia (2005) 1.32
Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res (2000) 1.31
Cytotoxic drugs and the CD95 pathway. Leukemia (1999) 1.30
Betulinic acid: a new cytotoxic agent against malignant brain-tumor cells. Int J Cancer (1999) 1.28
Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood (1998) 1.25
Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci U S A (1999) 1.25
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system. Int J Cancer (1998) 1.24
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J (1997) 1.23
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia (1997) 1.19
Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII. Exp Clin Endocrinol Diabetes (2007) 1.19
c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol Cell Biol (2000) 1.18
Diagnosis of diabetes in cystic fibrosis and thalassemia major. Diabetes Care (1998) 1.10
Betulinic acid-induced apoptosis in leukemia cells. Leukemia (2004) 1.09
Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents. AIDS (1999) 1.08
Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood (1997) 1.08
Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest (1997) 1.08
Macrophage-activating factors from different T cell clones induce distinct macrophage functions. J Immunol (1983) 1.06
Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood (1995) 1.06
Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells. Cell Death Differ (1999) 1.06
Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res (1998) 1.06
Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res (1999) 1.06
Betulinic acid induces apoptosis through a direct effect on mitochondria in neuroectodermal tumors. Med Pediatr Oncol (2000) 1.05
Urinary excretion of albumin in adolescents with type 1 diabetes: persistent versus intermittent microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care (1999) 1.05
Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood (1992) 1.05
Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr (1995) 1.04
Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Blood (2000) 1.04
Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04
Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord (2004) 1.02
Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells. Biochemistry (1999) 1.01
[Bacteriophages of Propionibacterium acnes (author's transl)]. Zentralbl Bakteriol Orig A (1973) 1.01
Longitudinal anthropometric measurements in patients with growth hormone deficiency. Effect of human growth hormone treatment. Eur J Pediatr (1982) 1.00
Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. J Clin Endocrinol Metab (1995) 0.99
Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest (1986) 0.98
Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells. Oncogene (2008) 0.98
Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br J Pharmacol (1999) 0.98
Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). Int J Cancer (2000) 0.97
Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy. Diabet Med (2007) 0.97
CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood (1998) 0.97
N-myc augments death and attenuates protective effects of Bcl-2 in trophically stressed neuroblastoma cells. Oncogene (2008) 0.97
Pubertal development in obese children and adolescents. Int J Obes (Lond) (2007) 0.97
JNK/SAPK activity contributes to TRAIL-induced apoptosis. Cell Death Differ (1999) 0.97
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes (1998) 0.96
Glucose metabolism of isolated pancreatic islets: difference between fetal, newborn and adult rats. Endocrinology (1971) 0.96
MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells. Oncogene (1998) 0.95
Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease. Immunol Res (2009) 0.95
Socioeconomic conditions and type 1 diabetes in childhood in North Rhine-Westphalia, Germany. Diabetologia (2007) 0.94
FTO deficiency induces UCP-1 expression and mitochondrial uncoupling in adipocytes. Endocrinology (2013) 0.94
Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors. Mol Immunol (1984) 0.94
Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha. Oncogene (2000) 0.93
Contributions of age, gender and insulin administration to weight gain in subjects with IDDM. Diabetologia (1998) 0.93
HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels. BMC Mol Biol (2001) 0.93
Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J Virol (1996) 0.93
Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults. Diabetes Care (1999) 0.93
Direct costs of pediatric diabetes care in Germany and their predictors. Exp Clin Endocrinol Diabetes (2004) 0.92
Body composition in 5-18-y-old obese children and adolescents before and after weight reduction as assessed by deuterium dilution and bioelectrical impedance analysis. Am J Clin Nutr (1996) 0.92
Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children. Bone Marrow Transplant (1999) 0.92
NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene (2006) 0.91
The role of growth hormone/insulin-like growth factors in adipocyte differentiation. Metabolism (1995) 0.91
Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. Cancer Res (2000) 0.91
CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells. Adv Cancer Res (1998) 0.90
Betulinic acid: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin Padiatr (1999) 0.90
TRAIL induces apoptosis and activation of NFkappaB. Eur Cytokine Netw (1998) 0.90
Activation of the CD95 (APO-1/Fas) pathway in drug- and gamma-irradiation-induced apoptosis of brain tumor cells. Cell Death Differ (1998) 0.90